CPMV Mosaic Immunoengineering: institutional ownership and insider trading
1 funds reported holding $0 of Mosaic Immunoengineering in their latest 13F filings; in Q3 2025 funds net bought $0, with 0 new positions and 0 funds selling out.
1 funds reported holding $0 of Mosaic Immunoengineering in their latest 13F filings; in Q3 2025 funds net bought $0, with 0 new positions and 0 funds selling out.